What do the patients think of artificial pancreas?

Session Type
PARALLEL SESSION
Date
21.02.2020, Friday
Session Time
16:40 - 18:00
Channel
Rome
Lecture Time
17:30 - 17:55
Presenter
  • Katharine Barnard-Kelly, United Kingdom
Authors
  • Katharine Barnard-Kelly, United Kingdom

Abstract

Background and Aims / Part 1

Automated insulin delivery systems represent cutting edge technologies aimed at improving glycaemic control. With varying levels of interaction required across different systems, this lecture will explore facilitators and barriers to effective engagement with automated insulin delivery systems from both research and user perspectives

Methods

Mixed methods approach to understanding the hopes, anxieties, experience and unmet needs related to automated insulin delivery systems. Quantitative and qualitative data will be presented from our program of research into the lived experience and psychosocial aspects of automated insulin delivery systems for users and HCPs.

Methods / Part 2

Mixed methods approach to understanding the hopes, anxieties, experience and unmet needs related to automated insulin delivery systems. Quantitative and qualitative data will be presented from our program of research into the lived experience and psychosocial aspects of automated insulin delivery systems for users and HCPs.

Results

Results will be presented reporting qualitative interviews and additional data. Data from different key stakeholder perspectives, i.e. adults, children, parents and partners living with Type 1 diabetes as well as healthcare professionals.

Results / Part 3

Results will be presented reporting qualitative interviews and additional data. Data from different key stakeholder perspectives, i.e. adults, children, parents and partners living with Type 1 diabetes as well as healthcare professionals.

Conclusions

Results will be discussed in the context of personalised diabetes management, individualised needs and challenges posed. Unmet needs will be examined in the context of healthcare delivery and support required by healthcare professionals and people living with diabetes.

Conclusions / Part 4

Results will be discussed in the context of personalised diabetes management, individualised needs and challenges posed. Unmet needs will be examined in the context of healthcare delivery and support required by healthcare professionals and people living with diabetes.
Hide